Patient advocates argue that that opioid prescribing limits harm those people requiring the medications most.
Scott Martin Vouri, Pharm.D., Ph.D., BCPG, an assistant professor of pharmaceutical outcomes and policy, was recently awarded a K08 Career Development Award through the National Institute on Aging to further his work on prescribing cascades in older adults. Prescribing cascades describe a problem in medication use where a drug-induced…
The department of pharmaceutical outcomes and policy celebrated its 2020 and spring 2021 graduates during ceremonies in April and May.
The U.S. Food and Drug Administration in 2016 took action to reduce the overuse of fluoroquinolones, a type of antibiotic associated with serious side effects. That step helped cut the use of these antibiotics for uncomplicated urinary tract infections, or UTIs, by more than half, according to a University…
The study assessed the association of GLP-1RA and chronic lower respiratory disease exacerbation in a population with comorbid Type 2 diabetes and CLRD.
The UF College of Pharmacy’s 2021 Annual Research Showcase featured a record number of poster presentations, as participants embraced a new format in the midst of the COVID-19 pandemic. With the addition of a new postdoctoral trainee category, the event also featured more oral presentations than ever before. The hybrid…
Successful applicants will join the University of Florida’s Artificial Intelligence Initiative aimed at advancing the university to a national and world-wide leader in the application of AI.
Drs. Amie Goodin and Juan Hincapie-Castillo have joined the Opioid Data Lab.
PhRMA has awarded a $25,000 grant through its Collaborative Actions to Reach Equity program to Dr. Vakaramoko “Karam” Diaby.
The study led by Dr. Weihsuan "Jenny" Lo-Ciganic was published by PLOS One.